DB17858InvestigationalGene Therapies
CTx-PDE6b is an adeno-associated virus (AAV) based gene therapy designed to deliver a full-length non-mutated copy of the functional human PDE6b gene. Being commercialied by Coave Therapeutics, it is being...
- Also known as
- AAV2/5-hPDE6B · CTx PDE6B · HORA PDE6B · HORA-PDE6B
What you can answer from here — as of January 07, 2026
Which companies are running trials of CTx-PDE6b, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account